Management of Refractory Vomiting When Ondansetron and Metoclopramide Fail
When ondansetron (Emeset) and metoclopramide (Perinorm) fail to control vomiting, adding aprepitant (NK-1 receptor antagonist) combined with dexamethasone is the most effective next-line strategy to achieve symptom control. 1, 2
Step-by-Step Approach to Refractory Vomiting
First Assessment
- Determine the underlying cause of vomiting:
- Medication-induced
- Gastrointestinal causes (obstruction, gastroparesis)
- CNS involvement
- Metabolic disturbances
- Psychogenic factors 1
Pharmacological Management
Add Dexamethasone:
- Add 8mg IV/PO daily to enhance antiemetic efficacy 1
- Particularly useful when there may be inflammation or edema contributing to symptoms
Add Aprepitant (NK-1 receptor antagonist):
Consider Olanzapine:
- Add 5-10mg PO daily for breakthrough nausea and vomiting 1
- Particularly effective for chemotherapy-induced nausea and vomiting
Administration Schedule:
- Administer antiemetics on a scheduled basis rather than PRN
- Combine medications from different antiemetic classes for synergistic effect 1
Alternative Approaches
Benzodiazepines can be effective for anticipatory nausea and vomiting, though efficacy may decrease over time 3
Behavioral therapies such as progressive muscle relaxation, systematic desensitization, and hypnosis can be effective but may be difficult to implement in acute settings 3
Chlorpromazine can be considered as an alternative, though it may have more side effects than newer agents 3
Supportive Measures
Dietary modifications:
- Small, frequent meals with low-fat content
- Separating liquids from solids
- Taking small bites and chewing thoroughly 1
Hydration:
- Ensure adequate fluid intake (≥1.5L/day)
- Vary temperature and flavors of liquids 1
Monitor for complications:
- Dehydration and electrolyte abnormalities
- Consider thiamin supplementation if vomiting persists >2-3 weeks 1
Red Flags Requiring Urgent Evaluation
- Severe abdominal pain
- Focal neurological findings
- Significant weight loss or malnutrition
- Signs of mechanical obstruction 1
Special Considerations
For chemotherapy-induced vomiting: The combination of a 5-HT3 receptor antagonist with dexamethasone and aprepitant has shown complete response rates of 42.9% in high-dose chemotherapy settings 3
For radiotherapy-induced vomiting: Antiemetic regimens should be tailored based on the irradiated area and emetogenic risk 3
For pediatric patients: Ondansetron has sufficient evidence for use in children, even though it may be considered "off-label/on-evidence" 4
Remember to reassess the antiemetic regimen daily and adjust based on response. The combination of medications from different antiemetic classes provides synergistic effects and improves control of refractory vomiting.